marketcaparena
Search

    EVH

    Evolent Health, Inc.

    Company overview

    Market capitalization
    $412.67M
    Employees
    4,200
    Latest publication
    2026-09-29
    About Evolent Health, Inc.

    Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ2 20242024-06-30 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ1 20222022-03-31 · USD
    Total Revenue652,520,000USD479,533,000USD444,328,000USD483,649,000USD647,145,000USD382,432,000USD352,585,000USD297,057,000USD
    Cost Of Revenue571,684,000USD403,674,000USD367,384,000USD381,178,000USD540,302,000USD299,368,000USD266,617,000USD219,739,000USD
    Gross Profit80,836,000USD75,859,000USD76,944,000USD102,471,000USD106,843,000USD83,064,000USD85,968,000USD77,318,000USD
    Selling General Administrative68,831,000USD77,592,000USD75,209,000USD78,409,000USD69,185,000USD117,887,000USD55,821,000USD58,932,000USD
    Total Operating Expenses90,397,000USD75,201,000USD74,118,000USD104,093,000USD99,055,000USD84,942,000USD73,017,000USD80,116,000USD
    Operating Income-9,561,000USD658,000USD2,826,000USD-1,622,000USD7,788,000USD-1,878,000USD12,951,000USD-2,798,000USD
    Total Other Income Expense Net-16,088,000USD-20,616,000USD-23,548,000USD-61,526,000USD-6,430,000USD-8,349,000USD-56,344,000USD-1,350,000USD
    Interest Income703,000USD964,000USD1,084,000USD1,274,000USD1,370,000USD5,196,000USD425,000USD117,000USD
    Interest Expense16,859,000USD16,475,000USD11,601,000USD10,385,000USD5,995,000USD6,429,000USD4,754,000USD2,241,000USD
    Depreciation And Amortization21,566,000USD26,796,000USD24,427,000USD24,058,000USD29,870,000USD19,781,000USD17,196,000USD15,106,000USD
    Income Before Tax-25,649,000USD-19,958,000USD-20,722,000USD-63,148,000USD1,358,000USD-10,227,000USD-43,393,000USD-4,148,000USD
    Income Tax Expense2,715,000USD906,000USD-825,000USD1,470,000USD-238,000USD1,122,000USD-45,516,000USD1,202,000USD
    Equity Method Income Loss-41,000USD———————
    Net Income-28,364,000USD-20,864,000USD-19,897,000USD-64,618,000USD1,596,000USD-11,349,000USD2,123,000USD-5,350,000USD
    Net Income Applicable To Common Shares-28,364,000USD-26,930,000USD-51,090,000USD-72,250,000USD—-11,349,000USD2,123,000USD-5,350,000USD
    Research Development—5,600USD——6,700,000USD7,400,000USD6,400,000USD4,100,000USD
    Unclassified Operating Expenses—-2,396,600USD-1,091,000USD25,684,000USD23,170,000USD-40,345,000USD10,796,000USD17,084,000USD
    Net Interest Income—-15,511,000USD-10,517,000USD-9,111,000USD-4,625,000USD-5,825,000USD-4,329,000USD-2,124,000USD
    Tax Provision—906,000USD-825,000USD1,470,000USD-238,000USD1,122,000USD-45,516,000USD1,202,000USD
    Net Income From Continuing Ops—-20,864,000USD-19,897,000USD-64,618,000USD1,596,000USD-11,349,000USD2,123,000USD-5,350,000USD
    Ebit—-3,483,000USD-9,121,000USD-52,763,000USD6,470,000USD-3,798,000USD-38,639,000USD-1,907,000USD
    Ebitda—23,313,000USD15,306,000USD-28,705,000USD36,340,000USD15,983,000USD-21,443,000USD13,199,000USD
    Reconciled Depreciation—23,615,000USD23,141,000USD24,058,000USD29,870,000USD19,781,000USD17,196,000USD15,106,000USD
    Non Operating Income Net Other—————11,352,000USD-8,720,000USD891,000USD
    Discontinued Operations———————-463,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20222022-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue1,876,229,000USD1,352,013,000USD100,888,000USD
    Cost Of Revenue1,592,197,000USD1,035,429,000USD73,122,000USD
    Gross Profit284,032,000USD316,584,000USD27,766,000USD
    Selling General Administrative303,866,000USD245,747,000USD76,521,000USD
    Unclassified Operating Expenses-15,399,000USD40,195,000USD-105,767,000USD
    Total Operating Expenses288,467,000USD312,942,000USD-25,246,000USD
    Operating Income-4,435,000USD3,642,000USD-25,246,000USD
    Interest Income4,190,000USD9,634,000USD—
    Interest Expense57,471,000USD15,572,000USD0USD
    Net Interest Income-53,281,000USD-14,203,000USD—
    Income Before Tax-534,635,999USD-62,077,000USD-25,246,000USD
    Income Tax Expense-126,000USD-43,376,000USD0USD
    Tax Provision-126,000USD-43,376,000USD—
    Net Income-534,510,000USD-19,164,000USD-25,246,000USD
    Net Income From Continuing Ops-534,510,000USD-18,701,000USD-25,246,000USD
    Ebit-477,164,999USD-46,505,000USD-25,246,000USD
    Ebitda-361,313,999USD43,746,000USD-25,246,000USD
    Depreciation And Amortization115,851,000USD90,251,000USD—
    Reconciled Depreciation115,851,000USD67,195,000USD—
    Total Other Income Expense Net-530,200,999USD-65,719,000USD-25,246,000USD
    Net Income Applicable To Common Shares-579,401,000USD-19,164,000USD-31,137,000USD
    Research Development—27,000,000USD4,000,000USD
    Non Operating Income Net Other—5,995,000USD—
    Discontinued Operations—-463,000USD—
    Minority Interest——285,238,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,971,894,000USD1,878,847,000USD1,899,236,000USD2,453,459,000USD2,461,532,000USD2,653,451,000USD2,544,411,000USD2,501,764,000USD
    Cash And Equivalents115,703,000USD—151,856,000USD116,650,000USD150,995,000USD246,547,000USD104,203,000USD96,583,000USD
    Total Current Assets610,510,000USD502,010,000USD506,372,000USD570,094,000USD562,257,000USD727,934,000USD607,117,000USD544,011,000USD
    Other Current Assets22,699,000USD21,847,000USD31,118,000USD66,880,000USD52,506,000USD50,891,000USD88,233,000USD39,526,000USD
    Total Liabilities1,588,671,000USD———————
    Total Current Liabilities492,833,000USD381,235,000USD385,260,000USD429,927,000USD557,519,000USD739,097,000USD715,501,000USD523,683,000USD
    Other Current Liabilities43,897,000USD———————
    Other Non Current Liabilities8,092,000USD———————
    Total Stockholder Equity383,223,000USD396,393,000USD415,194,000USD842,233,000USD896,005,000USD935,521,000USD1,001,259,000USD1,038,685,000USD
    Total Equity Including Noncontrolling Interest383,223,000USD———————
    Long Term Debt966,467,000USD973,486,000USD970,537,000USD1,054,822,000USD648,455,000USD647,532,000USD490,520,000USD599,668,000USD
    Deferred Revenue1,208,000USD———————
    Net Receivables449,118,000USD314,158,000USD323,398,000USD386,564,000USD358,756,000USD430,496,000USD414,681,000USD407,902,000USD
    Property Plant Equipment Net84,631,000USD85,047,000USD85,158,000USD-53,644,000USD82,615,000USD80,166,000USD79,285,000USD83,185,000USD
    Goodwill694,434,000USD———————
    Intangible Assets554,427,000USD569,682,000USD584,937,000USD762,260,000USD651,169,000USD667,881,000USD680,156,000USD696,779,000USD
    Accounts Payable38,823,000USD63,007,000USD59,776,000USD72,180,000USD69,460,000USD57,813,000USD96,025,000USD50,087,000USD
    Short Term Debt1,541,000USD8,779,000USD15,343,000USD23,060,000USD196,327,000USD206,980,000USD198,184,000USD6,220,000USD
    Common Stock1,187,000USD1,185,000USD1,176,000USD1,176,000USD1,175,000USD1,174,000USD1,166,000USD1,166,000USD
    Retained Earnings-1,370,323,000USD-1,341,959,000USD-1,315,327,000USD-886,196,000USD-865,332,000USD-845,435,000USD-780,817,000USD-758,015,000USD
    Accumulated Other Comprehensive Income-3,626,000USD-3,626,000USD-2,624,000USD-2,376,000USD-1,707,000USD-1,729,000USD-1,753,000USD-1,367,000USD
    Total Liab—1,482,454,000USD1,484,042,000USD1,611,226,000USD1,565,527,000USD1,717,930,000USD1,543,152,000USD1,463,079,000USD
    Other Current Liab—308,032,000USD308,938,000USD332,816,000USD289,399,000USD469,287,000USD418,785,000USD464,755,000USD
    Capital Stock—1,185,000USD1,176,000USD1,176,000USD1,175,000USD1,174,000USD1,166,000USD1,166,000USD
    Good Will—694,433,000USD694,482,000USD1,075,376,000USD1,137,321,000USD1,137,320,000USD1,137,320,000USD1,137,342,000USD
    Cash—166,005,000USD151,856,000USD116,650,000USD150,995,000USD246,547,000USD104,203,000USD96,583,000USD
    Cash And Short Term Investments—166,005,000USD151,856,000USD116,650,000USD150,995,000USD246,547,000USD104,203,000USD96,583,000USD
    Current Deferred Revenue—1,417,000USD1,203,000USD1,871,000USD2,333,000USD5,017,000USD2,507,000USD2,621,000USD
    Net Debt—819,420,000USD837,842,000USD965,665,000USD702,198,000USD623,550,000USD609,470,000USD538,623,000USD
    Short Long Term Debt Total—985,425,000USD989,698,000USD1,082,315,000USD853,193,000USD870,097,000USD713,673,000USD635,206,000USD
    Long Term Investments—8,955,000USD8,966,000USD8,936,000USD8,978,000USD8,569,000USD8,588,000USD8,405,000USD
    Property Plant Equipment Gross—296,920,000USD290,932,000USD284,467,000USD275,959,000USD267,149,000USD259,161,000USD256,126,000USD
    Common Stock Shares Outstanding—111,905,000shares114,208,000shares114,066,000shares115,882,000shares115,315,000shares115,032,000shares114,862,000shares
    Non Current Assets Total—1,376,837,000USD1,392,864,000USD1,883,365,000USD1,899,275,000USD1,925,517,000USD1,937,294,000USD1,957,753,000USD
    Non Current Liabilities Total—1,101,219,000USD1,098,782,000USD1,181,299,000USD1,008,008,000USD978,833,000USD827,651,000USD939,396,000USD
    Non Current Liabilities Other—8,091,000USD8,012,000USD3,784,000USD3,787,000USD3,269,000USD2,984,000USD3,247,000USD
    Non Currrent Assets Other—15,981,000USD19,321,000USD90,437,000USD19,192,000USD31,581,000USD31,945,000USD32,042,000USD
    Net Working Capital—120,775,000USD121,112,000USD140,167,000USD4,738,000USD-11,163,000USD-108,384,000USD20,328,000USD
    Unclassified Non Current Liabilities—119,642,000USD120,233,000USD122,693,000USD355,766,000USD328,032,000USD334,147,000USD336,481,000USD
    Unclassified Equity—1,739,608,000USD1,730,793,000USD1,728,453,000USD1,760,694,000USD1,780,337,000USD1,781,497,000USD1,795,735,000USD
    Other Assets——19,321,000USD90,437,000USD19,192,000USD31,581,000USD31,945,000USD32,042,000USD
    Unclassified Non Current Assets——-19,321,000USD-144,081,000USD-19,192,000USD-31,581,000USD-31,945,000USD-32,042,000USD
    Short Long Term Debt———5,118,000USD172,119,000USD171,793,000USD171,467,000USD—
    Unclassified Current Liabilities———-5,118,000USD-172,119,000USD-171,793,000USD-171,467,000USD—
    Short Term Investments——————59,295,000USD16,343,000USD
    Unclassified Current Assets——————-59,295,000USD-16,343,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,899,236,000USD2,544,411,000USD2,680,308,000USD1,817,293,000USD1,419,458,000USD1,474,439,000USD1,498,015,000USD1,722,281,000USD
    Intangible Assets584,937,000USD680,156,000USD752,009,000USD442,784,000USD279,784,000USD264,992,000USD308,459,000USD335,036,000USD
    Other Current Assets31,118,000USD28,938,000USD44,099,000USD35,170,000USD127,076,000USD89,880,000USD48,568,000USD98,823,000USD
    Total Liab1,484,042,000USD1,543,152,000USD1,612,607,000USD957,876,000USD725,825,000USD854,839,000USD568,968,000USD532,925,000USD
    Total Stockholder Equity415,194,000USD1,001,259,000USD1,067,701,000USD859,417,000USD693,633,000USD619,600,000USD922,358,000USD1,189,356,000USD
    Other Current Liab308,938,000USD418,785,000USD610,282,000USD363,388,000USD330,396,000USD327,218,000USD129,184,000USD102,012,000USD
    Common Stock1,176,000USD1,166,000USD1,154,000USD1,015,000USD908,000USD859,000USD846,000USD823,000USD
    Capital Stock1,176,000USD1,166,000USD1,154,000USD1,015,000USD908,000USD859,000USD846,000USD823,000USD
    Retained Earnings-1,315,327,000USD-780,817,000USD-719,194,000USD-606,154,000USD-626,779,000USD-589,178,000USD-251,962,000USD50,009,000USD
    Good Will694,482,000USD1,137,320,000USD1,116,542,000USD722,774,000USD426,297,000USD349,029,000USD572,064,000USD768,124,000USD
    Other Assets19,321,000USD31,945,000USD33,012,000USD32,305,000USD52,391,000USD186,468,000USD91,994,000USD121,145,000USD
    Cash151,856,000USD104,203,000USD192,825,000USD188,200,000USD266,280,000USD333,376,000USD101,008,000USD228,320,000USD
    Cash And Equivalents151,856,000USD104,203,000USD192,825,000USD188,200,000USD266,280,000USD319,002,000USD101,008,000USD228,320,000USD
    Cash And Short Term Investments151,856,000USD163,498,000USD192,825,000USD188,200,000USD266,280,000USD333,376,000USD102,815,000USD228,320,000USD
    Total Current Assets506,372,000USD607,117,000USD683,673,000USD478,054,000USD523,960,000USD547,649,000USD228,801,000USD487,966,000USD
    Total Current Liabilities385,260,000USD715,501,000USD674,242,000USD433,442,000USD445,493,000USD403,294,000USD192,769,000USD146,760,000USD
    Current Deferred Revenue1,203,000USD2,507,000USD5,976,000USD5,758,000USD11,944,000USD10,187,000USD19,828,000USD20,584,000USD
    Net Debt837,842,000USD609,470,000USD451,971,000USD287,918,000USD14,187,000USD26,407,000USD267,786,000USD-7,279,000USD
    Short Term Debt15,343,000USD198,184,000USD9,738,000USD7,122,000USD7,069,000USD33,914,000USD6,269,000USD122,596,000USD
    Short Long Term Debt Total989,698,000USD713,673,000USD644,796,000USD476,118,000USD280,467,000USD359,783,000USD368,794,000USD343,637,000USD
    Long Term Debt970,537,000USD490,520,000USD597,049,000USD412,986,000USD215,676,000USD263,343,000USD293,667,000USD221,041,000USD
    Long Term Investments8,966,000USD8,588,000USD4,895,000USD4,475,000USD5,458,000USD17,417,000USD139,369,000USD16,286,000USD
    Net Receivables323,398,000USD414,681,000USD446,749,000USD254,684,000USD130,604,000USD124,393,000USD77,418,000USD82,310,000USD
    Accounts Payable59,776,000USD96,025,000USD48,246,000USD57,174,000USD96,084,000USD31,975,000USD37,488,000USD146,760,000USD
    Property Plant Equipment Net85,158,000USD79,285,000USD90,177,000USD136,901,000USD131,568,000USD144,039,000USD157,328,000USD73,628,000USD
    Property Plant Equipment Gross290,932,000USD259,161,000USD248,746,000USD287,378,000USD250,666,000USD144,039,000USD157,328,000USD73,628,000USD
    Accumulated Other Comprehensive Income-2,624,000USD-1,753,000USD-1,257,000USD-1,178,000USD-362,000USD-278,000USD-234,000USD-182,000USD
    Common Stock Shares Outstanding114,208,000shares114,682,000shares111,251,000shares93,699,000shares86,067,000shares84,928,000shares82,364,000shares77,338,000shares
    Non Current Assets Total1,392,864,000USD1,937,294,000USD1,996,635,000USD1,339,239,000USD895,498,000USD926,790,000USD1,269,214,000USD1,113,170,000USD
    Non Current Liabilities Total1,098,782,000USD827,651,000USD938,365,000USD524,434,000USD280,332,000USD451,545,000USD376,199,000USD386,165,000USD
    Non Current Liabilities Other8,012,000USD2,984,000USD3,637,000USD106,704,000USD63,253,000USD84,735,000USD80,590,000USD17,090,000USD
    Non Currrent Assets Other19,321,000USD31,945,000USD33,012,000USD32,305,000USD52,391,000USD48,285,000USD91,994,000USD6,105,000USD
    Net Working Capital121,112,000USD-108,384,000USD9,431,000USD44,612,000USD78,467,000USD144,355,000USD36,032,000USD218,610,000USD
    Unclassified Non Current Assets-19,321,000USD-31,945,000USD-33,012,000USD-32,305,000USD-52,391,000USD-83,440,000USD-91,994,000USD-207,154,000USD
    Unclassified Non Current Liabilities120,233,000USD334,147,000USD337,679,000USD-55,438,000USD-6,934,000USD-352,435,000USD-13,674,000USD80,068,000USD
    Unclassified Equity1,730,793,000USD1,781,497,000USD1,785,844,000USD1,464,719,000USD1,340,081,000USD1,228,461,000USD1,172,862,000USD1,137,883,000USD
    Short Long Term Debt—171,467,000USD———26,557,000USD——
    Short Term Investments—59,295,000USD13,768,000USD14,492,000USD75,685,000USD3,858,000USD1,807,000USD818,000USD
    Unclassified Current Liabilities—-171,467,000USD———-26,557,000USD—-245,192,000USD
    Inventory——1USD-415,926,000USD-308,222,000USD-445,098,000USD-150,086,000USD78,513,000USD
    Unclassified Current Assets——-13,768,001USD-14,492,000USD-75,685,000USD———
    Deferred Long Term Liab———4,744,000USD1,403,000USD728,000USD1,942,000USD25,438,000USD
    Other Liab———55,438,000USD6,934,000USD455,174,000USD13,674,000USD42,528,000USD
    Net Tangible Assets———-306,141,000USD-12,448,000USD-3,206,000USD41,835,000USD40,664,000USD
    Treasury Stock————-21,123,000USD-21,123,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-26,632,000USD-429,131,000USD-20,864,000USD-64,618,000USD-22,802,000USD-23,137,000USD1,596,000USD-17,280,000USD
    Depreciation22,486,000USD-45,037,000USD23,615,000USD26,449,000USD30,490,000USD29,701,000USD30,984,000USD29,503,000USD
    Stock Based Compensation10,649,000USD-2,396,000USD14,682,000USD11,081,000USD-6,115,000USD14,416,000USD12,659,000USD18,786,000USD
    Other Non Cash Items14,116,000USD487,224,000USD9,139,000USD54,403,000USD12,432,000USD5,566,000USD15,995,000USD30,847,000USD
    Change To Account Receivables-4,297,000USD66,339,000USD-48,561,000USD-15,815,000USD-6,782,000USD-34,177,000USD54,012,000USD19,009,000USD
    Change In Working Capital-11,531,000USD36,463,000USD-11,387,000USD-23,045,000USD-45,278,000USD-6,939,000USD-25,998,000USD-38,342,000USD
    Total Cash From Operating Activities-984,000USD48,800,000USD15,812,000USD4,565,000USD-26,231,000USD18,670,000USD21,417,000USD4,909,000USD
    Capital Expenditures-6,406,000USD-7,761,000USD-8,962,000USD-8,595,000USD-6,150,999USD-6,289,000USD-7,106,000USD-5,347,000USD
    Free Cash Flow-7,390,000USD41,039,000USD6,850,000USD-4,030,000USD-32,381,999USD12,381,000USD14,311,000USD-438,000USD
    Total Cashflows From Investing Activities-6,406,000USD82,153,000USD-8,762,000USD-13,093,000USD-19,930,000USD-19,729,000USD-13,541,000USD-9,732,000USD
    Net Borrowings0USD-95,422,000USD1,985,000USD158,500,000USD59,105,000USD0USD——
    Total Cash From Financing Activities-3,973,000USD-93,036,000USD-41,815,000USD107,854,000USD96,942,000USD-9,008,000USD-103,381,000USD14,882,000USD
    Dividends Paid0USD0USD-1,929,000USD-4,577,000USD-4,806,000USD-5,134,000USD-5,067,000USD-5,078,000USD
    Sale Purchase Of Stock-1,816,000USD-51,123,000USD-39,996,000USD-4,593,000USD-310,000USD-692,000USD-364,000USD-14,334,000USD
    Change In Cash-11,985,000USD37,651,000USD-35,024,000USD99,349,000USD50,572,000USD-8,377,000USD-95,438,000USD10,148,000USD
    Begin Period Cash Flow177,990,000USD140,339,000USD175,363,000USD178,496,000USD112,926,000USD121,303,000USD216,741,000USD206,593,000USD
    End Period Cash Flow166,005,000USD177,990,000USD140,339,000USD277,845,000USD163,498,000USD112,926,000USD121,303,000USD216,741,000USD
    Other Cashflows From Financing Activities-2,157,000USD2,386,000USD-1,875,000USD-41,476,000USD42,644,000USD-6,217,000USD-98,375,000USD19,431,000USD
    Unclassified Operating Cash Flow-10,072,000USD1,677,000USD——5,042,000USD—-13,819,000USD-18,605,000USD
    Other Cashflows From Investing Activities—91,312,000USD-50,561,000USD-4,498,000USD-13,778,000USD-16,940,000USD-4,562,000USD-1,385,000USD
    Unclassified Investing Cash Flow—-1,398,000USD59,523,000USD13,093,000USD19,928,999USD23,229,000USD11,668,000USD6,732,000USD
    Unclassified Financing Cash Flow—51,123,000USD———3,035,000USD—14,863,000USD
    Investments——-8,762,000USD-13,093,000USD-19,930,000USD-19,729,000USD-13,541,000USD-9,732,000USD
    Issuance Of Capital Stock————0USD0USD0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income-61,623,000USD-113,040,000USD-19,164,000USD-37,601,000USD-334,246,000USD-301,971,000USD-54,191,000USD-69,767,000USD
    Depreciation125,615,000USD123,415,000USD67,195,000USD60,037,000USD61,475,000USD66,635,999USD44,515,000USD32,368,000USD
    Stock Based Compensation39,746,000USD40,501,000USD33,981,000USD16,711,000USD14,606,000USD15,618,000USD17,609,000USD20,437,000USD
    Other Non Cash Items34,400,000USD101,086,000USD10,534,000USD13,771,000USD298,391,000USD215,483,000USD6,238,000USD3,559,000USD
    Change To Account Receivables32,062,000USD-164,694,000USD-102,980,000USD-5,779,000USD-47,017,000USD6,326,000USD-24,503,000USD-11,258,000USD
    Change In Working Capital-116,557,000USD21,892,000USD-104,441,000USD-13,645,000USD-55,319,000USD331,000USD-34,866,000USD-7,284,000USD
    Total Cash From Operating Activities18,765,000USD142,582,000USD-11,553,000USD38,747,000USD-16,225,000USD-42,645,000USD-20,651,000USD-27,958,000USD
    Capital Expenditures-24,893,000USD-28,745,000USD-38,361,000USD-24,983,000USD-29,473,000USD-35,534,000USD-39,550,000USD-27,848,000USD
    Free Cash Flow-6,128,000USD113,837,000USD-49,914,000USD13,764,000USD-45,698,000USD-78,179,000USD-60,201,000USD-55,806,000USD
    Investments-62,932,000USD-413,948,000USD36,521,000USD54,219,000USD-10,064,000USD-93,700,000USD8,916,000USD23,082,000USD
    Total Cashflows From Investing Activities-62,932,000USD-415,544,000USD-259,115,000USD-15,786,000USD261,072,000USD-181,634,000USD-160,375,000USD-12,265,000USD
    Net Borrowings58,576,000USD183,293,000USD219,740,000USD-98,849,000USD13,456,000USD-41,620,000USD263,331,000USD-4,200,000USD
    Total Cash From Financing Activities-565,000USD281,340,000USD131,541,000USD-29,548,000USD-11,862,000USD-35,545,000USD274,024,000USD165,557,000USD
    Dividends Paid-20,085,000USD-18,793,000USD-14,884,000USD-1,300,000USD-20,000,000USD-61,131,000USD—0USD
    Sale Purchase Of Stock-16,624,000USD-15,292,000USD-10,432,000USD11,989,000USD-17,423,000USD-2,609,000USD-1,236,000USD-1,272,000USD
    Issuance Of Capital Stock0USD168,000,000USD0USD0USD—0USD0USD—
    Change In Cash-44,961,000USD8,299,000USD-139,784,000USD-6,639,000USD233,050,000USD-262,443,000USD92,962,000USD125,334,000USD
    Begin Period Cash Flow223,457,000USD215,158,000USD354,942,000USD361,581,000USD128,531,000USD382,827,000USD295,363,000USD170,029,000USD
    End Period Cash Flow178,496,000USD223,457,000USD215,158,000USD354,942,000USD361,581,000USD120,384,000USD388,325,000USD295,363,000USD
    Other Cashflows From Investing Activities-30,718,000USD-387,669,000USD-295,636,000USD-70,005,000USD271,136,000USD-41,000,000USD28,437,000USD-20,000,000USD
    Other Cashflows From Financing Activities-42,517,000USD-63,679,000USD146,425,000USD70,601,000USD24,744,000USD-99,285,000USD106,846,000USD-1,390,000USD
    Unclassified Operating Cash Flow-2,816,000USD-31,272,000USD——-1,132,000USD-38,741,999USD—-7,271,000USD
    Unclassified Investing Cash Flow55,611,000USD414,818,000USD38,361,000USD24,983,000USD29,473,000USD-11,400,000USD-158,178,000USD12,501,000USD
    Unclassified Financing Cash Flow20,085,000USD195,811,000USD-209,308,000USD-11,989,000USD-12,639,000USD169,100,000USD-94,917,000USD172,419,000USD
    Change To Inventory—-10,746,000USD—-14,116,000USD47,017,000USD-19,503,000USD644,000USD-1,834,000USD
    Change To Liabilities——-16,886,000USD7,730,000USD31,657,000USD-23,441,000USD17,381,000USD1,245,000USD
    Cash And Cash Equivalents Changes——-139,127,000USD-6,587,000USD232,985,000USD-259,824,000USD92,998,000USD125,334,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2022Yearly · 2022-12-31SegmentClinical Solutions944,511,000USD0001628908-23-000029
    FY 2022Yearly · 2022-12-31SegmentEvolent Health Services407,502,000USD0001628908-23-000029
    Q4 2022Quarterly · 2022-12-31SegmentClinical Solutions281,452,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31SegmentEvolent Health Services100,980,000USDLegacy provider
    Q3 2022Quarterly · 2022-09-30SegmentClinical Solutions245,257,000USD0001628908-22-000141
    Q3 2022Quarterly · 2022-09-30SegmentEvolent Health Services107,328,000USD0001628908-22-000141
    Q2 2022Quarterly · 2022-06-30SegmentClinical Solutions227,603,000USD0001628908-22-000098
    Q2 2022Quarterly · 2022-06-30SegmentEvolent Health Services92,336,000USD0001628908-22-000098
    Q1 2022Quarterly · 2022-03-31SegmentClinical Solutions190,199,000USD0001628908-22-000063
    Q1 2022Quarterly · 2022-03-31SegmentEvolent Health Services106,858,000USD0001628908-22-000063
    FY 2021Yearly · 2021-12-31SegmentClinical Solutions598,144,000USD0001628908-23-000029
    FY 2021Yearly · 2021-12-31SegmentEvolent Health Services309,813,000USD0001628908-23-000029
    Q4 2021Quarterly · 2021-12-31SegmentClinical Solutions161,103,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31SegmentEvolent Health Services87,255,000USDLegacy provider
    FY 2021Yearly · 2021-12-31ProductPlatforms And Operations Services896,753,000USD0001628908-22-000027
    FY 2021Yearly · 2021-12-31ProductTransformation Services11,204,000USD0001628908-22-000027
    Q4 2021Quarterly · 2021-12-31ProductPlatforms And Operations Services242,138,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductTransformation Services6,220,000USDLegacy provider
    Q3 2021Quarterly · 2021-09-30SegmentClinical Solutions159,614,000USD0001628908-22-000141
    Q3 2021Quarterly · 2021-09-30SegmentEvolent Health Services62,857,000USD0001628908-22-000141
    Q3 2021Quarterly · 2021-09-30ProductPlatforms And Operations Services220,396,000USD0001628908-21-000149
    Q3 2021Quarterly · 2021-09-30ProductTransformation Services2,075,000USD0001628908-21-000149
    Q2 2021Quarterly · 2021-06-30SegmentClinical Solutions147,194,000USD0001628908-22-000098
    Q2 2021Quarterly · 2021-06-30SegmentEvolent Health Services74,863,000USD0001628908-22-000098
    Q2 2021Quarterly · 2021-06-30ProductPlatforms And Operations Services219,493,000USD0001628908-21-000116
    Q2 2021Quarterly · 2021-06-30ProductTransformation Services2,564,000USD0001628908-21-000116
    Q1 2021Quarterly · 2021-03-31SegmentClinical Solutions130,233,000USD0001628908-22-000063
    Q1 2021Quarterly · 2021-03-31SegmentEvolent Health Services84,838,000USD0001628908-22-000063
    Q1 2021Quarterly · 2021-03-31ProductPlatforms And Operations Services214,726,000USD0001628908-21-000054
    Q1 2021Quarterly · 2021-03-31ProductTransformation Services345,000USD0001628908-21-000054
    FY 2020Yearly · 2020-12-31SegmentClinical Solutions542,279,000USD0001628908-23-000029
    FY 2020Yearly · 2020-12-31SegmentEvolent Health Services382,360,000USD0001628908-23-000029
    FY 2020Yearly · 2020-12-31ProductPlatforms And Operations Services912,649,000USD0001628908-22-000027
    FY 2020Yearly · 2020-12-31ProductTransformation Services11,990,000USD0001628908-22-000027
    Q4 2020Quarterly · 2020-12-31ProductPlatforms And Operations Services245,346,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductTransformation Services1,190,000USDLegacy provider
    Q3 2020Quarterly · 2020-09-30ProductPlatforms And Operations Services234,765,000USD0001628908-21-000149
    Q3 2020Quarterly · 2020-09-30ProductTransformation Services4,807,000USD0001628908-21-000149
    Q2 2020Quarterly · 2020-06-30ProductPlatforms And Operations Services216,544,000USD0001628908-21-000116
    Q2 2020Quarterly · 2020-06-30ProductTransformation Services755,000USD0001628908-21-000116
    Q1 2020Quarterly · 2020-03-31ProductPlatforms And Operations Services215,994,000USD0001628908-21-000054
    Q1 2020Quarterly · 2020-03-31ProductTransformation Services5,238,000USD0001628908-21-000054
    FY 2019Yearly · 2019-12-31SegmentClinical Solutions278,217,000USD0001628908-22-000027
    FY 2019Yearly · 2019-12-31SegmentEvolent Health Services408,905,000USD0001628908-22-000027
    FY 2019Yearly · 2019-12-31ProductPlatforms And Operations Services671,919,000USD0001628908-22-000027
    FY 2019Yearly · 2019-12-31ProductTransformation Services15,203,000USD0001628908-22-000027
    FY 2018Yearly · 2018-12-31ProductPlatforms And Operations Services500,190,000USD0001628908-21-000026
    FY 2018Yearly · 2018-12-31ProductPremiums Revenue93,957,000USD0001628908-21-000026
    FY 2018Yearly · 2018-12-31ProductTransformation Services32,916,000USD0001628908-21-000026
    FY 2017Yearly · 2017-12-31SegmentServices434,950,000USD0001628908-19-000006
    FY 2017Yearly · 2017-12-31SegmentTrue Health0USD0001628908-19-000006
    FY 2017Yearly · 2017-12-31ProductPlatforms And Operations Services405,484,000USD0001628908-20-000032
    FY 2017Yearly · 2017-12-31ProductPremiums Revenue0USD0001628908-20-000032
    FY 2017Yearly · 2017-12-31ProductTransformation Services29,466,000USD0001628908-20-000032
    FY 2016Yearly · 2016-12-31SegmentServices254,188,000USD0001628908-19-000006
    FY 2016Yearly · 2016-12-31SegmentTrue Health0USD0001628908-19-000006
    FY 2016Yearly · 2016-12-31ProductPlatforms And Operations Services215,868,000USD0001628908-19-000006
    FY 2016Yearly · 2016-12-31ProductPremiums Revenue0USD0001628908-19-000006
    FY 2016Yearly · 2016-12-31ProductTransformation Services38,320,000USD0001628908-19-000006

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.